|
|
|
|||||
Archive:
| |||||
10, 2007) A human antibody administered in a single low dose in laboratory mouse models can repair myelin, the insulating covering of nerves that when damaged can lead to multiple sclerosis and other disorders. . (Science Daily)
Zoo Elephant Undergoing Herpes Treatment Nov 10, 2008
With funding from the Houston Zoo, the National Institutes of Health, the National Zoo and other institutions, researchers are studying the DNA of the virus in an effort to develop an antibody profile. Results could help determine how to treat the disease. (Click2Houston, TX)
New Role For Critical DNA Repair Molecule In Immune System Nov 10, 2008
To combat infection, these cells must have receptors that can recognize a foreign substance when they encounter it, beginning the process of producing an antibody to fight it. In mice lacking 53BP1, however, the sections of DNA, or loci, that must recombine to build these receptors are farther apart than normal, making their recombination much less likely, the researchers found. (Science Daily)
OncoMed raises $93M in add-on funding Nov 10, 2008
Proceeds from the financing will be used to support the advancement of the company s cancer stem cell antibody programs, including its lead compound and a second antibody, through Phase 2 clinical trials. Cancer stem cells a subset of cells found in tumors have the ability to self-renew and differentiate, driving the spread, growth or recurrence of the tumor. (San Jose Business Journal, CA)
Quintet of proteins forms new, early-warning blood test before heart attack strikes Nov 10, 2008
Simultaneously, they plan further analysis of the proteins to map their molecular structures, so that an antibody can be identified to bind to one or several of the proteins, laying the basis for a blood test for ischemia. And they will conduct tests to verify that their study findings also apply to ischemia in stroke. (EurekAlert!)
Gold Nanostars Hold Promise In Medical Diagnoses And Tests For Environmental Contaminants Nov 8, 2008
Nanostars could be attached to an antibody to search for antigens, or coupled with a dye to improve the effectiveness of different imaging tests. While silver enhances the Raman scattering more effectively, gold was chosen as the metallic base of the current nanoparticle because it is a stable metal that doesn't cause immune system reactions within the body. (Science Daily)
Hepatitis C Transmission Not Reduced By C-sections, Says New Study Nov 8, 2008
According to these new findings, if the Hepatitis C virus is undetectable antenatally despite the mother being antibody positive the patient can be reassured that the risk of vertical transmission to their child is minimal, and this is a significant development for patient counseling. This research is published in the American Journal of Obstetrics & Gynaecolog. (Science Daily)
Skin Cancer: Designer Molecule Tackles Malignant Cells By Two Completely Different Routes Nov 5, 2008
(July 16, 2004) Mayo Clinic researchers have manipulated a human antibody to induce an anti-tumor response in living mice that consistently curbs -- and often cures -- malignant melanoma, one of the most lethal. (Nov. (Science Daily)
Natl nano conference coming to Albany Nov 5, 2008
Topics include such subjects as the role of nanoscale in regenerative medicine, dendrimer nanocomposites, nanotechnology and antibody therapeutics, deciphering extracellular matrix-induced stem cell differentiation, nanobiomaterials as building blocks for nanoelectronics, and getting a start-up funded. Registration and booth-rental information is available. (Albany Business Review, NY)
Key To Aggressive Breast Cancer Discovered Nov 4, 2008
(July 10, 2007) A recent meta-analysis of five major breast cancer trials has confirmed that combination treatment with the antibody trastuzumab and chemotherapy improves survival in women with operable HER-2. (Mar. (Science Daily)
Transplantation: 'Molecular Miscegenation' Blurs The Boundary Between Self And Non-self Nov 3, 2008
26, 1998) Organ transplant rejection caused by CD4 T cells could be stopped in the future using a new hybrid antibody developed at National Jewish Medical and Research Center. . (Science Daily)
Systems Biology And Glycomics Applied To Study Of Human Inflammatory Diseases Nov 3, 2008
(May 15, 2008) Researchers have identified a specific carbohydrate structure that confers anti-inflammatory activity to a glycoprotein antibody that could lead to improved treatment of autoimmune diseases like. (Mar. (Science Daily)
'Credit Card' Test For Hundreds Of Diseases Nov 3, 2008
A card-like sample stick with multiple "addresses," each with an antibody that binds to a different kind of PSA, would be able to test a blood sample for multiple forms of PSA and for their relative abundances, and thus be more reliable in predicting prostate cancer, Porter says. "The same approach can be used to screen patients for other cancers or heart disease," Granger says. (Science Daily)
The Good News and Bad News About MS Oct 31, 2008
The University of Cambridge researchers tested Campath-1H, an artificially produced human antibody that was developed for use in a specialized cancer treatment. Campath-1H inactivates some cells important for the immune response in patients with early-phase MS. The study compared this medication with another drug already in use to treat MS, and the results were pretty striking. (Slate)
Now reduce food craving, burn calories Oct 30, 2008
Scientists at The Scripps Research have identified an antibody that works against the gastric hormone ghrelin, which has been linked to weight gain and fat storage through its metabolic actions ... The researchers observed during the study that the antibody catalyst GHR-11E11 led to a higher metabolic rate in fasting mice, and suppressed feeding following 24-hour food deprivation ... "Our study showed that this novel catalytic ghrelin antibody could specifically seek out and degrade ghrelin,"... (Times of India)
SQI Diagnostics Submits FDA 510(k) and Health Canada Medical Device License Filings for its Automated SQiDworks Platform and QuantiSpot RA Microarray Consumable Test Oct 29, 2008
Each of the 96 wells of the QuantiSpot device contains proprietary microarrays for duplicate antibody capture, in-sample calibration and redundant test controls. When combined with the SQiDworks fully-automated workstation, users are able to process multiplexed assays to quantify serum concentrations of up to 12 individual biomarkers or the qualitative detection of up to 24 biomarkers per patient. (Canada Newswire)
Increasing Number Of People Vaccinated Against Influenza Can Decrease Burden Of Disease Oct 29, 2008
(July 11, 2008) A new study in the journal Psychophysiology reveals that men, but not women, vaccinated in the morning produced a better peak antibody response to both hepatitis A and the influenza. (Feb. (Science Daily)
Fight Obesity With New Antibody That Degrades Appetite Stimulant? Oct 29, 2008
Fight Obesity With New Antibody That Degrades Appetite Stimulant ... Fight Obesity With New Antibody That Degrades Appetite Stimulant ... 28, 2008) Scientists from the Scripps Research Institute have discovered a catalytic antibody that degrades a known appetite stimulant. (Science Daily)
New intranasal influenza vaccine triggers robust immunity with significantly less antigen Oct 29, 2008
All three doses produced antibody responses substantially higher than those triggered by the standard intramuscular vaccine. The ferrets, which represent the most relevant influenza animal model for humans, were then challenged with live influenza virus, and all were protected. (EurekAlert!)
Breast Milk Molecule Gives Mom's Immunity to Baby Oct 28, 2008 Cancer Vaccine Shows Promise In Patients With Bowel, Kidney And Prostate Cancer Oct 27, 2008 DATA from Overseas Phase III Trial of "Actemra" a Humanized Anti-Human IL-6 Receptor Monoclonal Antibody, Demonstrates Efficacy in Preventing Structural Joint Damage in Rheumatoid Arthritis Patients Oct 27, 2008 Nigeria: Why People Flee From HIV/Aids Tests [analysis] Oct 26, 2008 XOMA Presents Data On XOMA 052, An Anti-IL-1 Beta Antibody, in Rheumatoid Arthritis and Acute Gout Animal Models Oct 26, 2008 Lexicon Presents Phase 1 Clinical Trial Results for LX2931 At American College of Rheumatology Annual Meeting Oct 26, 2008 Leukemia drug halts MS Oct 26, 2008 A reversal of thinking: How women with lupus can increase chance for healthy pregnancies Oct 26, 2008 Rapid HIV testing in the ER boosts diagnoses, screening Oct 26, 2008 MedImmune to present abstracts on RSV and influenza at 48th Annual ICAAC/46th Annual IDSA Meeting Oct 26, 2008 Thallion's TLN-4601 Inhibits Mutated K-Ras Signaling in Cancer Cells Oct 24, 2008 Common Respiratory Syncytial Virus May Hide In The Lungs, Lead To Asthma, Researchers Report Oct 23, 2008 New Study Finds Growth Factor Boosts Productivity in Mammalian Cell Culture Oct 23, 2008 New hope for multiple sclerosis sufferers Oct 23, 2008 Harmless virus may hide and cause asthma Oct 22, 2008 XOMA Enters Into $60 Million Committed Equity Financing Facility Oct 22, 2008 Scripps research scientists enhance immune system attacks on cancer Oct 22, 2008 Idexx building lab in Memphis Oct 21, 2008 Scientists map life's building blocks Oct 19, 2008 Nanodiamond Drug Device Could Transform Cancer Treatment Oct 16, 2008 Dangerous Dining Oct 14, 2008 Immunomedics Announces U.S. Patents Awarded for CD20 Antibody, Veltuzumab, and Reagents Used in Pretargeted Imaging and Therapies Oct 14, 2008 Liver transplant patients highly vulnerable to cancer Oct 14, 2008 RNA Molecules, Delivery System Improve Vaccine Responses, Effectiveness Oct 13, 2008 Breakout drug Oct 13, 2008 Body's anti-HIV drug explained Oct 13, 2008 Portrait of a tangled triangle Oct 12, 2008 Two new PDL directors get cash, options Oct 11, 2008 Double Flu Jab Needed Against Bird Flu Pandemic Oct 10, 2008 Genentech touts test of Rituxan plus chemo vs. leukemia Oct 8, 2008 What is the influence of tumor removal on the serum level of carbohydrate's antibody? Oct 8, 2008 Eli Lilly to buy ImClone for over $6 billion Oct 7, 2008 Biolex Therapeutics raises $60 million in series D round Oct 7, 2008 Winning the battle, losing the faith Oct 7, 2008 OncoMed spins first antibody into the clinic Oct 6, 2008 Your health: Itch and rash most likely due to preservative or fragrance in self-tanners (2) Oct 5, 2008 Cancer risk in liver transplant patients Oct 4, 2008 Novel Anti-tumor Vaccine Developed Oct 4, 2008 Liver Transplant Recipients Almost Three Times More Likely To Develop Cancer Oct 4, 2008 Genentech, Roche in cancer treatment collaboration Oct 4, 2008 Navy awards local scientist a contract to fight bioterrorism Oct 3, 2008 Changing Dosing, Administration Of Anthrax Vaccine Reduces Side Effects Oct 3, 2008 Scripps Research Institute and IAVI launch world's first dedicated HIV neutralizing antibody center Oct 3, 2008 Pfizer currently leads IGF development, metformin may enhance activity of antibody in trials Oct 3, 2008 Lilly is potential ImClone suitor with $6.1 billion offer Oct 3, 2008 PDL BioPharma names CEO for spin-off company Sep 25, 2008 Bordetella pertussis Isolates in Finland: Serotype and Fimbrial Expression Sep 25, 2008 Roche completes acquisition of ARIUS Sep 24, 2008 Possible marker for ovarian cancer found Sep 24, 2008 Affitech Announces Second Milestone in Roche Antibody Discovery Collaboration Sep 23, 2008 Key PDL patents under fire Sep 23, 2008 Cellerant signs $13.5M contract for radiation treatment Sep 23, 2008 XOMA to Webcast Analyst and Investor Event 'Interleukin-1 Blockers: Unlocking Their Potential in Diabetes and Beyond' On September 25 Sep 22, 2008 New Pegloticase and Treatment Failure Gout Data to be Featured in Six Abstracts At American College of Rheumatology 72nd Annual Scientific Meeting Sep 22, 2008 The Role of B Lymphocytes in Autoim... Sep 21, 2008 Mother's Flu Shot Protects Newborns Sep 20, 2008 Researchers Invigorate 'Exhausted' Immune Cells Sep 19, 2008 Trillium secures additional financing on the strength of lead program and proprietary position around the CD200 immunoregulatory pathway Sep 18, 2008 Celiac Disease Sep 18, 2008 An 'HIV-test' Equivalent For Early Detection Of Lung Cancer Sep 18, 2008 Human rabies vaccines harder to find this year Sep 18, 2008 CBDM.T®, The Market and Business Intelligence Company Reviews The Biomanufacturing Market Sep 15, 2008 Program makes hygiene exciting for kids Sep 13, 2008 Slim antibody pills next big thing? Sep 13, 2008 A novel receptor - ligand pathway for entry of Francisella tularensis in monocyte-like THP-1 cells: interaction between surface nucleolin and bacterial elongation factor Tu Sep 13, 2008
Antibody pathway to mammary glands channels protection against intestinal bugs, study says ... The team from Brigham Young, Harvard and Stanford universities found that normal lactating mice had hundreds of thousands of antibody-producing cells in their mammary glands, while mice without CCR10 had 70 times fewer such cells ... "But why is it good? One of the reasons is that mothers' milk carries protective antibodies which shield the newborn from infection, and this study demonstrates the... (MEDLINEplus)
Discovering More About Alzhiemer's Disease Oct 28, 2008
Scientists are now testing new supplements, vaccines and antibody infusions (IVIG). Karen and Keith say it really is a race against time. (W-USA News, DC)
" TroVax is made up of a modified virus (Modified Vaccinia Ankara (MVA)), which acts as a vehicle to transport a second component, a gene that produces an antigen that is present in most solid tumours, called 5T4. TroVax is injected into patients whose solid tumours have the 5T4 tumour antigen present, so that the vaccine can trigger the body's natural immune responses to mobilise against 5T4. "The virus acts as both a 'vehicle' to deliver the 5T4 antigen and as an 'adjuvant', which helps to... (Science Daily)
CEO: Severin Schwan (hereafter, "Roche")] announced today that the humanized anti-human IL-6 (interleukin-6) receptor monoclonal antibody, ActemraR (generic name: tocilizumab -genetical recombination-), co-developed by Chugai and Roche, has shown efficacy in inhibiting structural joint damage as a combination therapy with methotrexate (MTX) in rheumatoid arthritis patients in a double-blinded phase III trial ... ActemraR (humanized anti-human IL-6 receptor monoclonal antibody)ActemraR is a... (JCN Network, Japan)
When was the last time you went for an HIV antibody test. Was it done voluntarily or coercively. (allAfrica.com)
Oct. 25, 2008 (GLOBE NEWSWIRE) -- XOMA Ltd. (NasdaqGM: - ), a leader in the discovery and development of antibody therapeutics, today announced that its poster titled ``Efficacy Of XOMA 052 Anti-IL-1 Beta Antibody In The DBA/1 Mouse Collagen-Induced Arthritis Model'' will be presented at the American College of Rheumatology 2008 Annual Conference, on Sunday, October 26 from 9:00 AM until 11:00 AM in Hall A. The poster also contains data demonstrating that XOMA 052 blocks inflammation in a mouse... (Primezone Releases)
Lexicon has applied small molecule chemistry and antibody technology to these biologically-validated targets to create its extensive pipeline of clinical and preclinical programs. Lexicon's goal is to advance 10 drug candidates into human clinical trials by the end of 2010, the strategic objective of its 10TO10 program. (Primezone Releases)
Aletuzumab is a synthetic antibody which was first developed to treat leukaemias or blood cell cancers. Because it affects the immune system, the researchers thought that it might be beneficial in patients with MS, a condition in which the bodys immune system attacks the central nervous system. (NHS Choices)
The research effort, a multi-center research initiative lead by Jane Salmon, M.D., attending physician at Hospital for Special Surgery, is known as the PROMISSE (Predictors of pRegnancy Outcome: bioMarkers In antiphospholipid antibody Syndrome and Systemic lupus Erythematosus) Study ... Specifically, the researchers found that women who tested positive for an autoantibody called lupus anticoagulant were more likely to have complications such as miscarriage or preeclampsia during pregnancy ...... (EurekAlert!)
According to the Henry Ford study, patients who sought treatment for a STI in Henry Ford's Emergency Department from 2004-08 were screened for HIV using a rapid antibody test. The test, administered with a finger-stick for a blood sample, provides results for HIV infection in 20 minutes. (EurekAlert!)
Respiratory Syncytial Virus Therapy Utilizing Intranasally Delivered Motavizumab, a Monoclonal Antibody Against the Viral Fusion Protein (#V-4145) B. Richter, Tuesday, October 28, 2008, Hall C from 12:15 PM to 1:15 PM ... Therapeutic Addition of Motavizumab, a Monoclonal Antibody Against Respiratory Syncytial Virus, Modulates Epithelial Cell Responses to RSV Infection (#V-4146) S. Krishnan, Tuesday, October 28, 2008, Hall C from 12:15 PM to 1:15 PM ... This preclinical study tested whether... (EurekAlert!)
The Company's third product candidate, Shigamabs, is a dual antibody product for the treatment of Shigatoxin-producing E. coli bacterial infections. Additional information about the Company can be obtained at www. (CCNMatthews Press Releases)
They also found that infected mice treated with an anti-RSV antibody had less virus in the lungs and not only showed improvement during the acute disease, but also developed significantly less airway hyperreactivity and lung inflammation during the chronic phase of the disease. "If you use an antibody against RSV, you not only prevent acute disease from the infection but you can also prevent the development of the asthma phenotype, indicating that early interventions against the virus can have a... (Science Daily)
"In working with research collaborators in the industry and leading academic centers around the world, recombinant lactoferrin has been shown to promote cell growth and productivity in a variety of cell lines and also improves antibody product yields in mammalian cell culture," said Dr. Huang. "Since recombinant lactoferrin is well defined, it is an important component for adapting cells and transitioning cells from serum to animal free and completely defined cell culture media.". (Yahoo News -- Press Releases)
In 1984, Cambridge scientist Cesar Milstein was awarded the Nobel Prize for Physiology or Medicine, jointly with George Kohler, for inventing the technology to make large quantities of a desired type of monoclonal antibody. Further work in Cambridge, by Herman Waldmann and Greg Winter, led to the production of the first humanised monoclonal antibody for use as a medicine, Campath-1H, now known as alemtuzumab. (EurekAlert!)
Mice treated with an antibody -- an immune system protein -- targeted to RSV ended up with less virus in the lungs and developed significantly less airway hyperreactivity and lung inflammation. "We are currently doing a study in which we are treating kids with a new antibody that is very potent," Mejias said. (MSNBC -- Health)
XOMA discovers, develops and manufactures therapeutic antibody agents designed to treat inflammatory, autoimmune, infectious and cancerous diseases and is engaged in more than 16 active development projects. The Company's expanding pipeline includes XOMA 052, an anti-IL-1beta antibody, and XOMA 629, a synthetic antimicrobial peptide compound derived from bactericidal/permeability-increasing protein ... XOMA's proprietary development pipeline is primarily funded by multiple revenue streams... (Primezone Releases)
" Stimulating Killer T Cells In the new study, the researchers basically used two different strategies. First, they worked out a way to force T cellsthe immune system's killer cellsto become active and grow in the presence of tumor "antigens," the proteins on the outside of cancer cells that can stimulate an immune response. While these T cells recognize the tumor antigens, their response to them tends to be chronically weak because they are 'self'. "We have been working for years to find ways... (EurekAlert!)
for free extra services. Subscribe to Memphis Business Journal. (Memphis Business Journal, TN)
"To get an idea of how far we have come, in our first year we produced on antibody," said Uhln. "This year we are hoping we can make 3,000." The programme was launched in 2003, and with sufficient funding the first full version of the atlas could be available by 2014, Uhln believes. (India Times, India -- Health/Science)
The architecture of the device is amenable to housing small molecule, protein, antibody or RNA- or DNA-based therapeutics. This gives the technology the potential to impact a range of treatment strategies where implanted, long-term drug release is needed. (Science Daily)
A food allergy is an immune system response to a food that the body mistakenly believes is harmful, and in turn, sends a self-produced antibody to attack it. Here are the eight foods identified by the USDA as food allergens that MUST be identified in products under the Food Allergen Labeling and Consumer Protection Act of 2004: milk, eggs, fish (bass, flounder, cod), crustacean shellfish (crab, lobster, shrimp, etc), tree nuts (almonds, walnuts, pecans), peanuts, wheat and soybeans. (Daytona Beach News Journal)
MORRIS PLAINS, N.J., Oct. 14, 2008 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (NasdaqGM: - ), a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, announced that U.S. patent 7,435,803 was issued today covering the composition of matter and the use of humanized, chimeric and human anti-CD20 antibodies and antibody fusion proteins or fragments thereof comprising at least the veltuzumab antibody that targets the CD20 antigen present on... (Primezone Releases)
Last Updated: Tuesday 14 October 2008 07:45 GMT. by Published on October 12, 2008 - 0 comments. (TheMedGuru)
Physicians want to tailor the immune response because, Singh says, vaccines for parasitic infections may need more of an antibody response, while vaccines for viral infections need more of a cellular response, one that kills the infected cells. The team s delivery system would work for a wide range of diseases, making it a broad platform for infectious disease vaccines, Roy says. (Science Daily)
Herceptin, a man-made antibody, turns off the signals that fuel these breast tumors. In the future, Slamon says, doctors will increasingly prescribe drugs that are specially tailored to each of these subtypes. (USA Today -- News)
Other members of the APOBEC family serve important roles in antibody maturation, fat metabolism and heart development. Mapping the structure of APOBEC-3G at the atomic level is a goal that "has been sought after worldwide because of its significance," Chen said. (EurekAlert!)
It doesn't quite work; the two parts are not just different but so forcefully different as to produce antibody rejection. And she herself is only partly reconciled. (Boston Globe)
PDL said it will capitalize a spinoff company, called , with $375 million but retain the rights to antibody humanization revenues from current and future licensed products. It expects the spinoff to be completed by the end of the year. (San Francisco Business Times, CA)
In comparison, the unprimed subjects who were vaccinated for the first time needed two doses of vaccine and achieved protective levels of antibody after 6 weeks as expected. The results indicate that regardless of which avian strain individuals are originally primed with, they are quickly protected against a broad range of avian strains following their booster vaccine, even strains they were not initially inoculated against. (Science Daily)
-based Biogen Idec (Nasdaq: BIIB) discovered Rituxan, an antibody, and it was approved in 1997 to treat non-Hodgkin s lymphoma. Later it was approved for other uses, including against rheumatoid arthritis. (Sacramento Business Journal, CA)
What is the influence of tumor removal on the serum level of carbohydrate's antibody ... What is the influence of tumor removal on the serum level of carbohydrate's antibody ... They found that in gastrointestinal cancer, the TF antibody level was found to have elevated significantly after the removal of G3 tumors as compared with the preoperative level (u = 278. (EurekAlert!)
The 11F8 drug is an antibody that targets production of a protein found on the surface of many cancer cells. That protein, epidermal growth factor receptor, is also targeted by Erbitux. (MSNBC -- Business)
The company has two more drugs in its pipeline BLX-155, which is designed to dissolve blood clots; and BLX-301, an antibody developed to treat non-Hodgkin's B-cell lymphoma and other diseases. Those two drugs are in pre-clinical testing and are yet to begin the three rounds of human testing required by the U.S. Food and Drug Administration. (Raleigh Triangle Business Journal, NC)
Published: October 6, 2008. The lion of the people will turn on you," warned Mullah Wakil Ahmed Muttawakil, a former Taliban foreign minister, as we sipped green tea at his home in Kabul a few weeks ago. He noted that while Americans had been shocked by a series of spectacular insurgent attacks over the summer, the U.S.-led coalition faced a far greater danger than the resurgent Taliban: growing despair among average Afghans that their government is fundamentally illegitimate. Every aspect of... (International Herald Tribune -- Ed/Op)
headed into a Phase I study last month wrapped in cash, a major pharmaceutical deal and the belief that its monoclonal antibody treatments could shift the cancer-fighting landscape. The promise has attracted some $150 million including an extension of Series B financing this month and pieces of a $1. (San Francisco Business Times, CA)
There are blood tests that can help a doctor diagnose celiac disease, particularly the EMA (endomysial antibody) and tTG (tissue transglutaminase) tests. Comments. (Sioux Falls Tri-State Neighbor, SD)
By contrast, non-melanoma skin cancer was more common among older patients and those who had antibody induction therapy. In an accompanying editorial by Ashok Kumar Jain of the University of Rochester reviewed the Aberg et al findings alongside the rest of the literature, looking closely at patient age and duration of follow-up. (India Times, India -- Health/Science)
By adding a T-reg suppressor such as cyclosphosphamide or anti-CD25 antibody, the scientists were able to have a greater impact on preventing tumor growth using the ISAP approach. "For tumors like neuroblastoma, reduction to minimal residual disease with standard therapies like chemotherapy and/or surgical resection and subsequent treatment with this vaccine could quite possibly cure the patient of the disease in the not too distant future," said Dr. Sandler, lead author of the study. (Science Daily)
"Non-Hodgkin lymphoma, which included four cases of post-transplant lymphoproliverative disorder, occurred more frequently in males, in patients transplanted at a younger age and soon after transplantation." By contrast, non-melanoma skin cancer was more common among older patients and those who had antibody induction therapy. Interestingly, the authors found lower cancer incidence among patients with history of acute rejections, correlating most strongly with lymphomas. (Science Daily)
The companies will work on a humanized anti-CD20 monoclonal antibody engineered to increase both direct- and immune-mediated target cell death for the potential treatment of hematological malignancies and other oncology-related B-cell disorders such as non-Hodgkin s lymphoma ... GlycArt, a Swiss biotechnology company owned by Roche, is focused on antibody engineering to generate new, more-efficacious drug candidates that are jointly developed with Roche. (East Bay Business Times, CA)
Local scientist Andrew Hayhurst has discovered that the blood from llamas and camels contains an antibody that might be adapted as a sensor for detecting biological and chemical agents at shopping malls, airports and subways. Hayhurst, a virologist and antibody engineer, received the two-year contract from the U.S. Navy to support the development of portable, reusable biosensors that are able to withstand high temperatures and other extreme field conditions ... Hayhurst believes that this... (San Antonio Business Journal, TX)
The researchers found that at month 7, after completion of the priming series (1st four injections), all groups had serum antibody responses that were "noninferior to" (i ... "Our data demonstrate that a 3-IM regimen (omission of the week 2 dose) elicits serum antibody responses at month 7 that are noninferior when compared with regimens containing 4 doses of AVA (SQ or IM). Intramuscular administration was associated with a significant reduction in injection site AEs. Changing the injection... (Science Daily)
Under a five-year supplemental agreement extending the existing collaboration between IAVI and Scripps Research, IAVI will invest $30 million to support the creation of the world's only HIV Neutralizing Antibody Center comprised of multidisciplinary scientific teams, including IAVI scientists, focused on designing vaccines to prevent HIV infection ... This new center will link to an expanded international scientific Consortium, which was created and is currently project managed by IAVI and known... (EurekAlert! -- Business News)
The company will be closely monitoring whether use of diabetic drug metformin enhances the effect of its anti-IGF-I receptor antibody currently in development for non-small cell lung cancer (NSCLC), investigators added ... Pfizers fully human IgG2 antibody CP-751,871 has currently advanced to Phase III trials for the treatment of advanced NSCLC. Scientists want to see the results of clinical trials that test the hypothesis that targeting the IGF-I receptor will benefit cancer patients ...... (FT.com -- Markets)
Erbitux is a monoclonal antibody, a type of protein that blocks a molecule that spurs cancer cells to grow. The current version is made partly from a mouse antibody ... The new version would be a fully human antibody, which would presumably have fewer side effects. (International Herald Tribune -- Business)
"Faheem's impressive leadership abilities, as well as his deep experience in oncology-focused biologics, will help Facet Biotech deliver on its mission to discover and develop antibody therapeutics targeting oncology and immunologic disease." ... At the time PDL said its strategic objectives included spinning off its biotechnology assets into a separate publicly traded entity apart from its antibody humanization royalty assets and to capitalize the new biotechnology spin-off company with about... (East Bay Business Times, CA)
Serotyping was done by agglutination and serotype-specific antibody responses were determined by blocking ELISA. ... Results of serotype-specific antibody responses suggest that Fim2 strains could express Fim3 during infection, showing a difference in fimbrial expression between in vivo and in vitro. (BioMed Central)
- Gains access to new screening platform for antibody therapeutics BASEL, Switzerland, Sept. 24 /CNW/ - Roche (SWX: ROG) announced today that it has completed the acquisition of 100% of the issued and outstanding shares and warrants of ARIUS Research (TSX: ARI) ... ARIUS is the developer of a proprietary antibody platform called FunctionFIRST(TM), which rapidly identifies and selects antibodies based on their functional ability to affect disease before progressing into clinical development ...... (Canada Newswire)
D., the director of the lab where Li works, calls the discovery important because TEM1 will let researchers and doctors eventually image, or visualize, the cancer "and also target it therapeutically through a TEM1 antibody.". "I think it's very exciting that people are starting to get closer to a test that might be able to be used for screening," says Barbara Goff, M.D., director of gynecologic oncology at the University of Washington School of Medicine. (CNN -- Health)
OSLO, September 23 /PRNewswire/ -- Affitech AS, the Norwegian human antibody therapeutics company, today announced that it has accomplished the second milestone in its research and licensing collaboration with Roche to produce fully human recombinant antibodies against an unnamed oncology target. Affitech has successfully used its MBAS (Molecule Based Antibody Screening) system that included its proprietary antibody library and high throughput screening technology to identify several fully human... (PR Newswire)
PDL s Queen patents named for company co-founder Cary Queen are for its antibody humanization patents, which also are licensed to companies like (NYSE: DNA) for the anti-cancer drug Avastin. The patents expire in the United States in 2014. (San Francisco Business Times, CA)
a biotechnology company developing hematopoietic stem cell-based cellular and antibody therapies for blood disorders and cancer, said Monday it was awarded a $13. 5 million government contract. (San Jose Business Journal, CA)
Sept. 22, 2008 (GLOBE NEWSWIRE) -- XOMA Ltd. (NasdaqGM: - ), a leader in the discovery and development of antibody therapeutics, announced today that the company will host a live web cast of its analyst and investor event on September 25, 2008 at 5:00 PM Eastern ... The speakers will also highlight interim data from two Phase 1 studies of XOMA 052, an anti-IL-1 beta antibody, in type 2 diabetes ... XOMA discovers, develops and manufactures therapeutic antibody agents designed to treat... (Primezone Releases)
Pegloticase treated patients with the highest anti-pegloticase antibody titers failed to maintain normalization of plasma uric acid. Additionally, pegloticase treated patients with the high anti-pegloticase antibody titers had a higher incidence of infusion-related reactions. (Primezone Releases)
This study is the direct result of a 5-year investigation into the role of Toll-like receptors in antibody production ... In their new study the Yale researchers found that this ability of self antigens to react with the Toll-like receptor stimulates B cells to begin autoantibody production ... Consequently, an ongoing process occurs in which autoantibody production persists. (Suite101.com)
19, 2008) Newborns can be protected from seasonal flu when their mothers are vaccinated during pregnancy, according to a study led by researchers at the Johns Hopkins Bloomberg School of Public Health. The researchers observed a 63 percent reduction in proven influenza illness among infants born to vaccinated mothers while the number of serious respiratory illnesses to both mothers and infants dropped by 36 percent. (Science Daily)
In their study, published online September 15 in the Proceedings of the National Academy of Sciences (PNAS), Wistar Institute investigators and colleagues report that using an antibody to block the receptor, known as programmed death-1 (PD-1), dramatically restored immunity in chronically infected mice ... Wherry's continuing research on PD-1 has provided the groundwork for developing antibody therapies that inhibit the receptor ... In follow-up experiments, they found that if they blocked PD-1... (Science Daily)
The company's two preclinical programs, a CD200-specific monoclonal antibody for the treatment of cancer, and a CD200Fc fusion protein for the treatment of autoimmune and inflammatory diseases, continue to hold promise and to generate strong scientific and commercial interest ... Trillium has two preclinical programs targeting the CD200 immunoregulatory axis; a CD200-specific monoclonal antibody for the treatment of cancer and a CD200Fc fusion protein for the treatment of autoimmune and... (Canada Newswire)
Gluten Free Diet May Not Offer Protection. Gluten is in many processed foods, including meats (canned and cold cuts), salad dressings, condiments, soups, flavored yogurt, and even herbal teas. (Suite101.com)
D., and colleagues at the Hutchinson Center and University of Michigan found that just as the immune system reacts to the presence of HIV by producing an antibody response, which indicates a person is HIV positive, it also mounts a response against specific antigens, or proteins, produced by cancerous lung tumors in their early stages of development. "This kind of immune response won't necessarily kill the tumor, but it can act as a canary in a coal mine, signaling lung cancer at an early stage,... (Science Daily)
They should also receive a dose of an antibody that provides immediate, but temporary, protection. But this summer and fall around most of the country doctors are being forced to be choosier about who gets vaccinated for rabies. (Scripps Howard News Wire)
Microbial fermentation is used when smaller and less complex molecules with no post-translational modifications are required (peptides, small proteins, enzymes and antibody fragment). Mammalian cell culture is definitely dominating the manufacturing of complex proteins (glycosylated) and monoclonal antibodies. (Yahoo News -- Press Releases)
com will teach elementary school children how to wash their hands properly to prevent the spread of the antibody resistant germ staphylococcus aureus, also known as MRSA.. Diane Mayberry, infection prevention specialist at Timpanogos Regional Hospital, said doctors are working to bring the Web site to local school districts and health fairs. (The Daily Universe, UT)
Slim antibody pills next big thing ... Slim antibody pills next big thing ... LONDON: GlaxoSmithKline Plc's head of biotech research is excited about a new generation of "slimline" antibody medicines that may be successors to current blockbusters such as Avastin and Rituxan. (India Times, India)
A specific polyclonal murine antibody was raised against recombinant LVS EF-Tu. By fluorescence and electron microscopy experiments, we found that a fraction of EF-Tu could be detected at the bacterial surface. (BioMed Central)
Back to Chemistry News
©1998-2009 SurfWax, Inc.
All rights reserved. Patents pending.
Copyright SurfWax, Inc. 2009 |